Browse medicines, page 24 of 40

Use listed on the medicine record

Regul Oil Cleansing Cream indications

Use listed on the medicine record

Temporarily relieves pain and itching associated with: • insect bites • minor burns • minor cuts • minor skin irritations • scrapes • sunburn • rashes due to poison ivy, poison oak, or poison sumac

Use listed on the medicine record

Adults and children 12 years of age : apply generously to the affected area, massage into painful area until thoroughly absorbed into the skin, repeat as necessary, but not more than 3 to 4 times daily. Children under 12 years of age : ask a doctor.

Use listed on the medicine record

For mydriasis and cycloplegia for diagnostic procedures.

Use listed on the medicine record

TUKYSA is a kinase inhibitor indicated: • in combination with trastuzumab and capecitabine for treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer, including patients with brain metastases, who have received one or more prior anti-HER2-based regimens in the metastatic setting. ( 1.1 ) • in combination with trastuzumab for the treatment of adult patients with RAS wild-type HER2-positive unresectable or metastatic colorectal cancer that has progressed following treatment with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy.

Use listed on the medicine record

Gallstone formation in obese patients experiencing rapid weight loss

Use listed on the medicine record

Anemia due to chronic kidney disease

Use listed on the medicine record

Duchenne muscular dystrophy

Use listed on the medicine record

Unresectable or metastatic melanoma with BRAF V600E mutation as detected by an FDA-approved test

Use listed on the medicine record

Estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, estrogen receptor-1 (ESR1) -mutated

Use listed on the medicine record

Adults and children 7 years and older: Spray into the nose 3 times a day

Use listed on the medicine record

Generalized myasthenia gravis

Use listed on the medicine record

INSTRUCTIONS FOR USE 1. Cleanse and moisturize. 2. Apply the mask evenly to the face, avoiding eyes and mouth. 3. Let dry for 15 mins, then sleep. 4. Remove mask or rinse next morning.

Use listed on the medicine record

CIBINQO is indicated for the treatment of adults and pediatric patients 12 years of age and older with refractory, moderate-to-severe atopic dermatitis whose disease is not adequately controlled with other systemic drug products, including biologics, or when use of those therapies is inadvisable. Limitations of Use CIBINQO is not recommended for use in combination with other JAK inhibitors, biologic immunomodulators, or other immunosuppressants.

Use listed on the medicine record

Presbyopia

Use listed on the medicine record

Severe psoriasis

Use listed on the medicine record

The maintenance treatment of patients with chronic obstructive pulmonary disease

Use listed on the medicine record

The signs and symptoms of dry eye disease

Use listed on the medicine record

The cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis

Use listed on the medicine record

KRAZATI is an inhibitor of the RAS GTPase family indicated for: Non-small cell lung cancer (NSCLC)* • As a single agent, for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic NSCLC, as determined by an FDA-approved test, who have received at least one prior systemic therapy.

Use listed on the medicine record

Intravenous adenosine injection, USP is indicated for the following: Conversion to sinus rhythm of paroxysmal supraventricular tachycardia (PSVT), including that associated with accessory bypass tracts (Wolff-Parkinson-White Syndrome). When clinically advisable, appropriate vagal maneuvers (e.g., Valsalva maneuver), should be attempted prior to adenosine injection, USP administration. It is important to be sure the adenosine injection, USP solution actually reaches the systemic circulation (see DOSAGE AND ADMINISTRATION ).

Use listed on the medicine record

Metastatic squamous NSCLC progressing after platinum-based chemotherapy

Use listed on the medicine record

Symptomatic obstructive hypertrophic cardiomyopathy (oHCM) to improve functional capacity and symptoms

Use listed on the medicine record

INDICATIONS& USAGE Suitable for all types of skin damage due to stretching of the skin. Apply all over skin, concentrating on tummy, hips, thighs and bust.Massage liberally into skin twice daily.

Use listed on the medicine record

Generalized anxiety disorder

Use listed on the medicine record

Alvimopan capsules are indicated to accelerate the time to upper and lower gastrointestinal recovery following surgeries that include partial bowel resection with primary anastomosis. Alvimopan capsules are an opioid antagonist indicated to accelerate the time to upper and lower gastrointestinal recovery following surgeries that include partial bowel resection with primary anastomosis. ( 1 )

Use listed on the medicine record

Amikacin Sulfate Injection is indicated in the short-term treatment of serious infections due to susceptible strains of Gram-negative bacteria, including Pseudomonas species, Escherichia coli , species of indole-positive and indole-negative Proteus , Providencia species, Klebsiella-Enterobacter-Serratia species, and Acinetobacter ( Mima-Herellea ) species.

Use listed on the medicine record

Amiloride HCl tablets are indicated as adjunctive treatment with thiazide diuretics or other kaliureticdiuretic agents in congestive heart failure or hypertension to: a. help restore normal serum potassium levels in patients who develop hypokalemia on the kaliuretic diuretic b. prevent development of hypokalemia in patients who would be exposed to particular risk if hypokalemia were to develop, e.g., digitalized patients or patients with significant cardiac arrhythmias.

Use listed on the medicine record

Diagnostic Positron Emission Tomography (PET) imaging of the myocardium under rest or pharmacologic stress conditions to evaluate myocardial

Use listed on the medicine record

Symptoms of depression

Use listed on the medicine record

Amphetamine sulfate tablets, USP 5 mg and 10 mg are indicated for: 1. Narcolepsy 2. Attention Deficit Disorder with Hyperactivity as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate to severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity.

Use listed on the medicine record

The following infections

Use listed on the medicine record

Nestabs® One is a prescription prenatal multi-vitamin/mineral supplement with DHA that can be taken throughout pregnancy and during the postnatal period for both lactating and non-lactating mothers. Nestabs® One may also be useful in improving the nutritional status of women prior to conception. The usual dose is one softgel daily, or as directed by a physician.

Use listed on the medicine record

The acute, intermittent treatment of hypomobility, "off" episodes

Use listed on the medicine record

Neurological manifestations of Niemann-Pick disease type C

Use listed on the medicine record

Local, infiltrative, or conductive anesthesia in both simple and complex dental procedures

Use listed on the medicine record

Asenapine sublingual tablets are indicated for: Schizophrenia in adults [see Clinical Studies (14.1) ] Bipolar I disorder [see Clinical Studies (14.2) ] Acute monotherapy of manic or mixed episodes, in adults and pediatric patients 10 to 17 years of age Adjunctive treatment to lithium or valproate in adults Maintenance monotherapy treatment in adults Asenapine sublingual tablets are an atypical antipsychotic indicated for ( 1 ): Schizophrenia in adults Bipolar I disorder Acute monotherapy treatment of manic or mixed episodes, in adults and pediatric patients 10 to 17 years of age Adjunctive…

Use listed on the medicine record

TAVNEOS is indicated as an adjunctive treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (granulomatosis with polyangiitis [GPA] and microscopic polyangiitis [MPA]) in combination with standard therapy including glucocorticoids. TAVNEOS does not eliminate glucocorticoid use.

Use listed on the medicine record

Complicated intra-abdominal infections (cIAI) including those caused by the following susceptible gram-negative microorganisms

Use listed on the medicine record

KRAS -mutated recurrent low-grade serous ovarian cancer (LGSOC) who have received prior systemic therapy

Use listed on the medicine record

Advanced renal cell carcinoma (RCC) after failure of one prior systemic therapy